CHENGDU KANGHUA BIOLOGICAL PRODUCTS
Kanghua Biological is a research and development, production, and operation of preventive biological products. The company's research and development, production base, SPF laboratory animal center, and high-tech bacterial and virus vaccine GMP production workshop occupy 30,000 square meters. Its existing product includes ACYW135 group Meningococcal Polysaccharide Vaccine, (trade name: Maicred) and Freeze-dried Rabies Vaccine for Human Use (Human Diploid Cells), (trade name: HDCV). It has been a... warded the titles of "Postdoctoral Innovation Practice Base", "Sichuan Province Constructive Innovation Enterprise Cultivation Enterprise", "Sichuan Province Excellent Integrity Demonstration Unit" by the Personnel Department and the Science and Technology Department. It was founded in 2004 in Chengdu, Sichuan, China.
CHENGDU KANGHUA BIOLOGICAL PRODUCTS
Social Links:
Industry:
Agriculture Biotechnology Life Science Product Research
Founded:
2004-01-01
Status:
Active
Contact:
(86) 028-84846555
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Font Awesome Domain Not Resolving Mobile Non Scaleable Content Euro Microsoft Azure DNS
Similar Organizations
Aat Bioquest
Aat Bioquest develops and produces bioreagents and kits for the photometric detection of molecules in biological signaling pathways.
Bigbang Angels
Bigbang Angels is an early stage cross-border accelerator and investor.
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
BVG Life Sciences
BVG Life Sciences is a research and development lab for human, plant and animal products.
FRD
FRD conducts the research and development of applications for plant fibers from biomass.
Languzhong Microbial Technology
Languzhong Microbial Technology is a researcher and producer of clostridium butyricum, feed fermentation inoculants and compound bacteria.
Panlabs Biologics
Panlabs Biologics is a contract research organization that provides tailored-made solutions for global enterprises.
Qualiplante
Qualiplante specializes in the development, production and commercialization of diagnostic tools for the detection of plant diseases.
Rodenburg Biopolymers
Rodenburg Biopolymers is engaged in the development, production, and sale of biodegradable biopolymer products.
Shanghai Institute of Biological Products
Shanghai Institute of Biological Products is a research institution for biological products.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-08 | Igenesis | Chengdu Kanghua Biological Products investment in Series C - Igenesis | 100 M CNY |
| 2020-11-05 | Abogen Biosciences | Chengdu Kanghua Biological Products investment in Series A - Abogen Biosciences | 150 M CNY |
More informations about "Chengdu Kanghua Biological Products"
Chengdu Kanghua Biological Products Co., …
Chengdu Kanghua Biological Products Co., Ltd. (hereinafter referredas “Kangh”) ,established in 2004, is one of the 13 enterprises with full vaccine production capacity in Chengdu …See details»
Company Profile - Kangh
Chengdu Kanghua Biological Products Co., Ltd. (hereinafter referredas “Kangh”) ,established in 2004, is one of the 13 enterprises with full vaccine production capacity in Chengdu Economic …See details»
Chengdu Kanghua Biological Products - Crunchbase
Kanghua Biological is a research and development, production, and operation of preventive biological products. The company's research and development, …See details»
成都康华生物制品股份有限公司
康华生物，成都康华生物制品股份有限公司See details»
Company Chengdu Kanghua Biological Products Co., Ltd.
May 31, 2010 Chengdu Kanghua Biological Products Co Ltd is a China-based company principally involved in the research and development, manufacturing and sales of vaccine …See details»
Chengdu Kanghua Biological Products - Craft
Oct 29, 2024 Chengdu Kanghua Biological Products ¥1.57 b in annual revenue in FY 2023. See insights on Chengdu Kanghua Biological Products including office locations, competitors, …See details»
Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ)
See the company profile for Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ) including business summary, industry/sector information, number of employees, business …See details»
Chengdu Kanghua Biological Products Co., Ltd.
了解Chengdu Kanghua Biological Products Co., Ltd. (成都康华生物制品股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的2项临床试验, 1篇新闻和9篇文献，疾病领域:感染，神 …See details»
Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ) …
[leftmenu] Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ) Company Profile [header] [overview] Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ) Annual Income …See details»
Chengdu Kanghua Biological Products - Simply Wall St
Mar 9, 2025 Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers …See details»
300841.SHE (Chengdu Kanghua Biological Products) | Historical …
4 days ago Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers …See details»
Post-IPO Secondary - Chengdu Kanghua Biological Products
Nov 8, 2024 Chengdu Kanghua Biological Products raised $49089047 on 2024-11-08 in Post-IPO Secondary. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
Long-term immunity and the effect of one or two booster doses …
The boosted vaccine was a lyophilized HDCV vaccine and developed by Chengdu Kanghua Biological products Co., Ltd. The vaccine currently available on the market in China (approval …See details»
中国证券报 - 成都康华生物制品股份有限公司<BR/>2022年第三季 …
Oct 25, 2022 本公司及董事会全体成员保证信息披露内容的真实、准确、完整、没有虚假记载、误导性陈述或重大遗漏。 成都康华生物制品股份有限公司（以下简称“公司”）于2022年10 …See details»
Chengdu Kanghua Biological Products - Crunchbase
Chengdu Kanghua Biological Products is registered under the ticker SZSE:300841 . Their stock opened with CN¥70.37 in its Jun 16, 2020 IPO. Chengdu Kanghua Biological Products is …See details»
HilleVax secures licensing agreement with Chengdu Kanghua for …
Jan 18, 2024 HilleVax has reached an exclusive licensing agreement with Chengdu Kanghua Biological Products (Kangh) for the rights to Kangh’s hexavalent virus-like particle (VLP) …See details»
77841 Chengdu Kanghua Biological Products Co. Ltd. - Fintel
77841 Chengdu Kanghua Biological Products Co. Ltd. - Class A (CNSZHK) - Share Price and News. Fintel ...See details»
Quotes Chengdu Kanghua Biological Products Co., Ltd.
Chengdu Kanghua Biological Products Co., Ltd.: End-of-day quote, intraday chart, variations, volumes, technical indicators and last transactions, Stock Chengdu ...See details»
Chengdu Kanghua Biological Products Dividends and Buybacks
Chengdu Kanghua Biological Products' (SZSE:300841) dividend yield is 3.65%. Dividend payments have decreased over the last 10 years and are covered by earnings with a payout …See details»
Chengdu Kanghua Biological Products Future Growth - Simply …
Chengdu Kanghua Biological Products (XSEC:300841) earnings and revenue forecasts, price targets, future return on equity. Compare Chengdu Kanghua Biological Products Co., Ltd.'s …See details»